LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | PD0325901 | 3.33 | uM | LJP5 | 72 | hr | 765 | 877 | 3124 | 0.2807 | 0.0474 |
Hs 578T | PD0325901 | 3.33 | uM | LJP6 | 72 | hr | 765 | 831 | 3124 | 0.2660 | 0.0280 |
Hs 578T | PD173074 | 3.33 | uM | LJP6 | 72 | hr | 765 | 2334 | 3124 | 0.7470 | 0.6650 |
Hs 578T | PD184352 | 3.33 | uM | LJP5 | 72 | hr | 765 | 1573 | 3124 | 0.5034 | 0.3424 |
Hs 578T | Pelitinib | 3.33 | uM | LJP5 | 72 | hr | 765 | 2021 | 3124 | 0.6470 | 0.5326 |
Hs 578T | PF431396 | 3.33 | uM | LJP5 | 72 | hr | 765 | 921 | 3124 | 0.2948 | 0.0661 |
Hs 578T | PF477736 | 3.33 | uM | LJP5 | 72 | hr | 765 | 532 | 3124 | 0.1705 | -0.0985 |
Hs 578T | PF562271 | 3.33 | uM | LJP6 | 72 | hr | 765 | 1526 | 3124 | 0.4885 | 0.3227 |
Hs 578T | PHA-665752 | 3.33 | uM | LJP5 | 72 | hr | 765 | 2945 | 3124 | 0.9425 | 0.9239 |
Hs 578T | PHA-793887 | 3.33 | uM | LJP6 | 72 | hr | 765 | 619 | 3124 | 0.1982 | -0.0618 |
Hs 578T | PI103 | 3.33 | uM | LJP6 | 72 | hr | 765 | 709 | 3124 | 0.2269 | -0.0238 |
Hs 578T | PLX-4720 | 3.33 | uM | LJP5 | 72 | hr | 765 | 3306 | 3124 | 1.0583 | 1.0772 |
Hs 578T | QL-X-138 | 3.33 | uM | LJP6 | 72 | hr | 765 | 1463 | 3124 | 0.4683 | 0.2960 |
Hs 578T | QL-XII-47 | 3.33 | uM | LJP6 | 72 | hr | 765 | 1207 | 3124 | 0.3864 | 0.1875 |
Hs 578T | Radicicol | 3.33 | uM | LJP5 | 72 | hr | 765 | 920 | 3124 | 0.2947 | 0.0660 |
Hs 578T | Radicicol | 3.33 | uM | LJP6 | 72 | hr | 765 | 865 | 3124 | 0.2768 | 0.0424 |
Hs 578T | Seliciclib | 3.33 | uM | LJP5 | 72 | hr | 765 | 3092 | 3124 | 0.9898 | 0.9865 |
Hs 578T | Ruxolitinib | 3.33 | uM | LJP5 | 72 | hr | 765 | 2778 | 3124 | 0.8892 | 0.8533 |
Hs 578T | XL147 | 3.33 | uM | LJP5 | 72 | hr | 765 | 2876 | 3124 | 0.9207 | 0.8950 |
Hs 578T | Saracatinib | 3.33 | uM | LJP6 | 72 | hr | 765 | 1957 | 3124 | 0.6264 | 0.5053 |
Hs 578T | Selumetinib | 3.33 | uM | LJP6 | 72 | hr | 765 | 1361 | 3124 | 0.4356 | 0.2526 |
Hs 578T | Sirolimus | 3.33 | uM | LJP6 | 72 | hr | 765 | 1851 | 3124 | 0.5926 | 0.4605 |
Hs 578T | Sorafenib | 3.33 | uM | LJP6 | 72 | hr | 765 | 3770 | 3124 | 1.2066 | 1.2736 |
Hs 578T | SU11274 | 3.33 | uM | LJP5 | 72 | hr | 765 | 2548 | 3124 | 0.8157 | 0.7559 |
Hs 578T | Fedratinib | 3.33 | uM | LJP5 | 72 | hr | 765 | 1001 | 3124 | 0.3204 | 0.1000 |